Articles

Washington University researchers have developed a potential cure for Type 2 diabetes.

A new form of insulin which is inhaled rather than injected works even if patients have a respiratory infections or are exposed to passive cigarette smoke.

Preliminary blinded results from it’s Phase IIa trial with E1-I.N.T. showed 3 of the first 4 type I diabetes patients had a 35-75% reduction in daytime insulin usage following a 28 day treatment.

Studies in animals suggest that brown seaweed, also known as wakame — commonly used to flavor Asian soups and salads, contains a compound that promotes weight loss. The compound, called fucoxanthin, also has anti-diabetes effects.

Actos® (pioglitazone HCl), an oral antidiabetic medication, demonstrated significant cardiovascular benefits in reducing the risk of heart attack and/or stroke and acute coronary syndrome in patients with type 2 diabetes.

While glucagon secretion is normally triggered by hypoglycemia and inhibited as glucose levels rises, it has now been shown that very high glucose levels paradoxically stimulate glucagon secretion

Researchers have made a breakthrough which could eventually help prevent people developing diabetes.

Amylin Pharmaceuticals, announced positive results from a recent 16-week study evaluating the safety and efficacy of adding SYMLIN®) (pramlintide acetate) to an established regimen of basal insulin glargine (with or without oral antidiabetic agents) in patients with type 2 diabetes who have not progressed to mealtime insulin therapy.

Three or four short, brisk walks throughout the day can be more helpful to people watching their blood pressure than one continuous bout of exercise, Indiana University researchers report.

Patients with diabetes and elevated fasting blood sugars have less capacity to exercise.